Detalles de la búsqueda
1.
Surgical outcomes and predictive value for major complications of robot-assisted radical cystectomy of real-world data in a single institution in Japan.
Int J Urol
; 2024 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38477173
2.
Geriatric Nutritional Risk Index as a Predictor of Prognosis in Metastatic Renal Cell Carcinoma Treated with Nivolumab.
Nutr Cancer
; 75(2): 670-677, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36448767
3.
Intensity-modulated radiation therapy for intermediate-risk prostate cancer: does ADT still have an impact in the dose-escalated external beam radiation therapy era?
Jpn J Clin Oncol
; 53(6): 514-521, 2023 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36946312
4.
Renal function outcome after selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and consolidative partial cystectomy in comparison with radical cystectomy for patients with muscle-invasive bladder cancer: a two-centre retrospective study.
Jpn J Clin Oncol
; 53(3): 263-269, 2023 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36524369
5.
A phase II randomized trial of metastasis-directed therapy with alpha emitter radium-223 in men with oligometastatic castration-resistant prostate cancer (MEDAL).
BMC Urol
; 23(1): 33, 2023 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36879257
6.
Real-world effectiveness of nivolumab and subsequent therapy in Japanese patients with metastatic renal cell carcinoma (POST-NIVO study): 36-month follow-up results of a clinical chart review.
Int J Urol
; 30(9): 762-771, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37248753
7.
Predictive ability of prebiopsy magnetic resonance imaging and biopsy for side-specific negative lymph node metastasis at radical prostatectomy.
Prostate
; 82(8): 904-910, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35297503
8.
Outcomes of intensity-modulated radiation therapy for intermediate- or high-risk prostate cancer: a single-institutional study.
Jpn J Clin Oncol
; 52(2): 170-178, 2022 Feb 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34689189
9.
Real-world use of enzalutamide in men with nonmetastatic castration-resistant prostate cancer in Japan.
Int J Clin Oncol
; 27(2): 418-426, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34779962
10.
Tumor shrinkage patterns of nivolumab monotherapy in metastatic renal cell carcinoma.
Int J Urol
; 29(10): 1181-1187, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35717138
11.
Early C-reactive protein kinetics predict survival of patients with advanced urothelial cancer treated with pembrolizumab.
Cancer Immunol Immunother
; 70(3): 657-665, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32876736
12.
External validation of the Briganti 2019 nomogram to identify candidates for extended pelvic lymph node dissection among patients with high-risk clinically localized prostate cancer.
Int J Clin Oncol
; 26(9): 1736-1744, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34117947
13.
Clinical features and outcomes of metastatic pheochromocytoma treated by cytotoxic chemotherapy.
Endocr J
; 68(6): 671-681, 2021 Jun 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-33518616
14.
Japanese single-institution analysis of mitotane for patients with adrenocortical carcinoma.
Endocr J
; 68(12): 1383-1390, 2021 Dec 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-34176818
15.
Adult genitourinary sarcoma: The era of optional chemotherapeutic agents for soft tissue sarcoma.
Int J Urol
; 28(1): 91-97, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33169456
16.
First-line combination chemotherapy with etoposide, ifosfamide and cisplatin for the treatment of disseminated germ cell cancer: Efficacy and feasibility in current clinical practice.
Int J Urol
; 28(9): 920-926, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34028113
17.
Oncological outcomes for patients with locally advanced prostate cancer treated with neoadjuvant endocrine and external-beam radiation therapy followed by adjuvant continuous/intermittent endocrine therapy in an open-label, randomized, phase 3 trial.
Cancer
; 126(17): 3961-3971, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32573779
18.
Prognostic Significance of the Controlling Nutritional Status (CONUT) Score in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab after Failure of Prior Tyrosine Kinase Inhibitors.
J Urol
; 204(6): 1166-1172, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32567459
19.
Efficacy and safety profile of nivolumab for Japanese patients with metastatic renal cell cancer.
Int J Clin Oncol
; 25(1): 151-157, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31522314
20.
A multicenter retrospective study of nivolumab monotherapy in previously treated metastatic renal cell carcinoma patients: interim analysis of Japanese real-world data.
Int J Clin Oncol
; 25(8): 1533-1542, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32519026